FDA advisers recommend COVID vaccines for kids under 5

Advisers to the US Food and Drug Administration have voted to recommend authorizing the emergency use of coronavirus vaccines from Pfizer and Moderna for children under the age of five.

In a meeting on Wednesday, the panel of outside experts unanimously agreed that each vaccine's benefits outweigh the risks.

If the FDA authorizes their use, it will be the first time for children under the age of five to be eligible for a coronavirus vaccine. The Pfizer vaccine is currently available for children aged five and over in the United States.

Pfizer filed for emergency use of its vaccine for children aged six months through four years.
Moderna also filed for use for children six months through five years.

The two pharmaceutical firms each presented the results of their clinical trials in the meeting. They explained that the vaccines proved effective for the age groups and no new safety concerns were found.

Some experts pointed out the need for careful consideration of vaccine use in light of the relatively low risk of children developing severe symptoms.

But the panel ultimately concluded that the age group should be given the choice to have a vaccine.

Pfizer's vaccine will be given in three shots that each contain one-tenth of the dose for adults.

Moderna's vaccine will be a two-shot regimen with each jab containing a quarter of the dose for adults.